{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:08:39Z","timestamp":1789560519281,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jiph.2025.102829","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T15:51:57Z","timestamp":1747237917000},"page":"102829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7374-8207","authenticated-orcid":false,"given":"Matthew Chung Yi","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-7281","authenticated-orcid":false,"given":"Jinghao Nicholas","family":"Ngiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9161-8177","authenticated-orcid":false,"given":"Lionel Hon-Wai","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nares","family":"Smitasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-6434","authenticated-orcid":false,"given":"Ka Lip","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Michael","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.102829_bib1","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.2147\/IDR.S371129","article-title":"Risk factors for mortality in hospitalized patients with stenotrophomonas maltophilia bacteremia","volume":"15","author":"Jian","year":"2022","journal-title":"Infect Drug Resist"},{"issue":"Pt 11","key":"10.1016\/j.jiph.2025.102829_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1099\/jmm.0.076513-0","article-title":"Stenotrophomonas maltophilia: an emerging pathogen in dialysis units","volume":"63","author":"De Mauri","year":"2014","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102829_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2169\/internalmedicine.56.6141","article-title":"Clinical characteristics of stenotrophomonas maltophilia bacteremia: a regional report and a review of a japanese case series","volume":"56","author":"Ebara","year":"2017","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4314\/ahs.v16i1.20","article-title":"Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens","volume":"16","author":"\u00c7\u2009\u0131kman","year":"2016","journal-title":"Afr Health Sci"},{"issue":"5","key":"10.1016\/j.jiph.2025.102829_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/antibiotics12050910","article-title":"Stenotrophomonas maltophilia infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options","volume":"12","author":"Maraolo","year":"2023","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jiph.2025.102829_bib6","doi-asserted-by":"crossref","unstructured":"Pranita D. Tamma, Emily L. Heil, Julie Ann Justo, Amy J. Mathers, Michael J. Satlin, Robert A. Bonomo, Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: Gram-Negative Bacterial Infections. Infectious Diseases Society of America 2024; Version 4.0. Available at https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/. Accessed 14\/07\/2024.","DOI":"10.1093\/cid\/ciae403"},{"issue":"9","key":"10.1016\/j.jiph.2025.102829_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00559-20","article-title":"Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant stenotrophomonas maltophilia","volume":"64","author":"Biagi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13613-023-01144-7","article-title":"Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study","volume":"13","author":"Chen","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.jiph.2025.102829_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14787210.2020.1730178","article-title":"Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge","volume":"18","author":"Gil-Gil","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/AAC.01020-12","article-title":"Coordinate hyperproduction of smez and smejk efflux pumps extends drug resistance in stenotrophomonas maltophilia","volume":"57","author":"Gould","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2025.102829_bib11","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1128\/AAC.00714-15","article-title":"The efflux pump SmeDEF contributes to trimethoprim-sulfamethoxazole resistance in stenotrophomonas maltophilia","volume":"59","author":"S\u00e1nchez","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-2994-2-1","article-title":"Access to antibiotics: a safety and equity challenge for the next decade","volume":"2","author":"Carlet","year":"2013","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"10.1016\/j.jiph.2025.102829_bib13","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/antibiotics11121788","article-title":"Combination therapy versus monotherapy in the treatment of stenotrophomonas maltophilia infections: a systematic review and meta-analysis","volume":"11","author":"Prawang","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12879-025-10636-9","article-title":"Clinical presentation and outcomes of bloodstream infection with intrinsically carbapenem-resistant non-fermenting gram-negative organisms: Stenotrophomonas maltophilia, Elizabethkingia spp. and Chryseobacterium spp. in Singapore, from 2012 to 2024","volume":"25","author":"Koh","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.102829_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/23744235.2024.2324365","article-title":"Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis","volume":"56","author":"Huang","year":"2024","journal-title":"Infect Dis (Lond)"},{"issue":"6","key":"10.1016\/j.jiph.2025.102829_bib16","first-page":"1106","article-title":"Upraising Stenotrophomonas maltophilia in Critically Ill Patients: A New Enemy?","volume":"13","author":"Dimopoulos","year":"2023","journal-title":"Diagn (Basel)"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jmii.2012.08.014","article-title":"Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections","volume":"47","author":"Chang","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"issue":"7","key":"10.1016\/j.jiph.2025.102829_bib18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10096-009-0709-5","article-title":"Community-acquired Stenotrophomonas maltophilia infections: a systematic review","volume":"28","author":"Falagas","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.102829_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QCO.0000000000000945","article-title":"Microbiotoxicity: antibiotic usage and its unintended harm to the microbiome","volume":"36","author":"Theodosiou","year":"2023","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2025.102829_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00479-23","article-title":"The impact of three carbapenems at a single-day dose on intestinal colonization resistance against carbapenem-resistant Klebsiella pneumoniae","volume":"8","author":"Kuang","year":"2023","journal-title":"mSphere"},{"issue":"9","key":"10.1016\/j.jiph.2025.102829_bib21","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.21846","article-title":"Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients","volume":"106","author":"Boktour","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jiph.2025.102829_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2007.10.033","article-title":"C-reactive protein is an independent predictor of severity in community-acquired pneumonia","volume":"121","author":"Chalmers","year":"2008","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.jiph.2025.102829_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jinf.2011.01.012","article-title":"C-Reactive protein levels but not CRP dynamics predict mortality in patients with pneumococcal pneumonia","volume":"62","author":"Mooiweer","year":"2011","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jiph.2025.102829_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ageing\/afp164","article-title":"C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia","volume":"38","author":"Thiem","year":"2009","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12941-024-00685-4","article-title":"Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"23","author":"Bostanghadiri","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"10.1016\/j.jiph.2025.102829_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106878","article-title":"In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020","volume":"62","author":"Lee","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65509-z","article-title":"Temporal analysis of prevalence and antibiotic-resistance patterns in Stenotrophomonas maltophilia clinical isolates in a 19-year retrospective study","volume":"14","author":"AlFonaisan","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib28","doi-asserted-by":"crossref","first-page":"9582","DOI":"10.1038\/s41598-021-88977-z","article-title":"Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran","volume":"11","author":"Azimi","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.jiph.2025.102829_bib29","first-page":"1215","article-title":"Cefiderocol: A Siderophore Cephalosporin","volume":"54","author":"El-Lababidi","year":"2020","journal-title":"Ann Pharm"},{"issue":"1","key":"10.1016\/j.jiph.2025.102829_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12866-021-02108-2","article-title":"Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jiph.2025.102829_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101750","article-title":"Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis","volume":"55","author":"Turjeman","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jiph.2025.102829_bib32","article-title":"Global prevalence and antibiotic resistance in clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis","volume":"10","author":"Banar","year":"2023","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:32:14Z","timestamp":1751581934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1876034125001789"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102829","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102829"}}